{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:49:03Z","timestamp":1785761343942,"version":"3.56.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC3607400, 2024YFC3607405"],"award-info":[{"award-number":["2024YFC3607400, 2024YFC3607405"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05092-9","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:24:55Z","timestamp":1780071895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological characteristics and renal outcomes of IgA nephropathy in systemic lupus erythematosus: a case report and systematic literature review"],"prefix":"10.1186","volume":"27","author":[{"given":"XiXi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhenZhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GuangYan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FengKun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XuanLi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhiYu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"7","key":"5092_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41584-025-01267-0","volume":"21","author":"E Patino-Martinez","year":"2025","unstructured":"Patino-Martinez E, Kaplan MJ. Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol. 2025;21(7):377\u201395.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"5092_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","volume":"82","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82(3):351\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5092_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.reuma.2010.11.001","volume":"7","author":"GS Alarcon","year":"2011","unstructured":"Alarcon GS. Multiethnic lupus cohorts: what have they taught us? Reumatol Clin. 2011;7(1):3\u20136.","journal-title":"Reumatol Clin"},{"issue":"3","key":"5092_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1191\/0961203302lu158oa","volume":"11","author":"HM Bastian","year":"2002","unstructured":"Bastian HM, Roseman JM, McGwin G Jr., Alarcon GS, Friedman AW, Fessler BJ, Baethge BA, Reveille JD. nurture LSGLiMpNv: Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus. 2002;11(3):152\u201360.","journal-title":"Lupus"},{"issue":"3","key":"5092_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00005792-199905000-00003","volume":"78","author":"R Cervera","year":"1999","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Aydintug AO, Jedryka-Goral A, de Ramon E, Fernandez-Nebro A, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. Med (Baltim). 1999;78(3):167\u201375. European Working Party on Systemic Lupus Erythematosus.","journal-title":"Med (Baltim)"},{"issue":"4","key":"5092_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D\u2019Agati VD, Ferrario F, Haas M, Jennette JC, et al. Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018;93(4):789\u201396.","journal-title":"Kidney Int"},{"key":"5092_CR7","doi-asserted-by":"crossref","unstructured":"Duran R, Yildirim D, Can Kardas R, Vasi I, Kaya B, Cakir Y, Karaduman I, Kucuk H, Goker B, Ozturk MA, Erden A. Lupus and IgA nephropathy: coexistence or coincident? Wien Klin Wochenschr; 2025.","DOI":"10.1007\/s00508-025-02512-y"},{"issue":"1","key":"5092_CR8","first-page":"5","volume":"8","author":"F Mac-Moune Lai","year":"1995","unstructured":"Mac-Moune Lai F, Li EK, Tang NL, Li PK, Lui SF, Lai KN. IgA nephropathy: a rare lesion in systemic lupus erythematosus. Mod Pathol. 1995;8(1):5\u201310.","journal-title":"Mod Pathol"},{"key":"5092_CR9","doi-asserted-by":"publisher","first-page":"289316","DOI":"10.1155\/2013\/289316","volume":"2013","author":"L Hongyan","year":"2013","unstructured":"Hongyan L, Yi Z, Bao D, Yuewu L, Juan M. A study on clinical and pathologic features in lupus nephritis with mainly IgA deposits and a literature review. Clin Dev Immunol. 2013;2013:289316.","journal-title":"Clin Dev Immunol"},{"key":"5092_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1681\/ASN.20233411S11124a","volume":"34","author":"KV Liang","year":"2023","unstructured":"Liang KV, Liang KP, Fields TA. IgA Nephropathy and Thrombotic Microangiopathy: A Rare Manifestation of Lupus After COVID-19 Infection. J Am Soc Nephrol. 2023;34:1124.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5092_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000511056","volume":"1","author":"L Bu","year":"2021","unstructured":"Bu L, Ye B, Kouri AM, Kim Y. Diagnostic Utility of Galactose-Deficient Immunoglobulin A1 Immunostaining in the Differentiation of Lupus Nephritis and Immunoglobulin A Nephropathy. Glomerular Dis. 2021;1(1):34\u20139.","journal-title":"Glomerular Dis"},{"issue":"5","key":"5092_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s13730-024-00860-8","volume":"13","author":"Y Iwafuchi","year":"2024","unstructured":"Iwafuchi Y, Morioka T, Oyama Y, Narita I. A case of non-lupus full-house nephropathy diagnosed by kidney biopsy but observed IgA nephropathy on second biopsy. CEN Case Rep. 2024;13(5):373\u201380.","journal-title":"CEN Case Rep"},{"issue":"2","key":"5092_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ki.1996.359","volume":"50","author":"R Topaloglu","year":"1996","unstructured":"Topaloglu R, Bakkaloglu A, Slingsby JH, Mihatsch MJ, Pascual M, Norsworthy P, Morley BJ, Saatci U, Schifferli JA, Walport MJ. Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family. Kidney Int. 1996;50(2):635\u201342.","journal-title":"Kidney Int"},{"key":"5092_CR14","doi-asserted-by":"crossref","unstructured":"Bernardino V, Mendes-Bastos P, Rodrigues A, Riso N. IgA vasculitis (formerly Henoch-Schonlein purpura) in an adult with systemic lupus erythematosus. BMJ Case Rep. 2015.","DOI":"10.1136\/bcr-2015-210121"},{"issue":"7","key":"5092_CR15","first-page":"1060","volume":"45","author":"M Bardi","year":"2018","unstructured":"Bardi M, Dehghan N. IGA vasculitis and lupus nephritis: a rare combo. J Rheumatol. 2018;45(7):1060.","journal-title":"J Rheumatol"},{"key":"5092_CR16","doi-asserted-by":"crossref","unstructured":"Bang S-Y, Kim G-H, Shin D, Park MH, Jun J-B. A case of IgA nephropathy associated with systemic lupus erythematosus. J Korean Rheum Association. 2009;16.","DOI":"10.4078\/jkra.2009.16.1.54"},{"issue":"10","key":"5092_CR17","first-page":"e230157","volume":"2","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Feng A. A Case Report of Systemic Lupus Erythematosus With IgA Nephropathy and Crescentic Nephritis. Annals Intern Medicine: Clin Cases. 2023;2(10):e230157.","journal-title":"Annals Intern Medicine: Clin Cases"},{"issue":"4","key":"5092_CR18","first-page":"S95","volume":"34","author":"O Magnani","year":"2016","unstructured":"Magnani O, Pellecchio M, Penza E, Murdaca G, Negrini S, Puppo F. Acute cardiac failure and IGA nephropathy: An uncommon SLE onset. Clin Exp Rheumatol. 2016;34(4):S95.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"5092_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10165-010-0345-z","volume":"21","author":"S Kobak","year":"2011","unstructured":"Kobak S, Hudaverdi O, Keser G, Oksel F. Coexistence of systemic lupus erythematosus, Hashimoto\u2019s thyroiditis and IgA nephropathy in the same patient. Mod Rheumatol. 2011;21(1):89\u201391.","journal-title":"Mod Rheumatol"},{"key":"5092_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5262\/tndt.2013.1003.11","volume":"22","author":"G Yildiz","year":"2013","unstructured":"Yildiz G, Cicekli E, Kayatas M, Yilmaz A, Candan F. IgA Nephropathy: A Rare Lesion in Renal Biopsy in Systemic Lupus Erythematosus: Case Reports and Review of Literature. Turkish Nephrol Dialysis Transplantation J. 2013;22:300\u20133.","journal-title":"Turkish Nephrol Dialysis Transplantation J"},{"key":"5092_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1681\/ASN.20213210S1819c","volume":"32","author":"G Wagler","year":"2021","unstructured":"Wagler G, Trivedi N, Dauleh MM, Zebi AM. Iga nephropathy and lupus nephritis: A subtype or a separate entity. J Am Soc Nephrol. 2021;32:819.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"5092_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/0961203309349384","volume":"19","author":"T Horino","year":"2010","unstructured":"Horino T, Takao T, Terada Y. IgA nephropathy in a patient with systemic lupus erythematosus. Lupus. 2010;19(5):650\u20134.","journal-title":"Lupus"},{"issue":"7","key":"5092_CR23","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/ndt\/13.7.1892","volume":"13","author":"C Basile","year":"1998","unstructured":"Basile C, Semeraro A, Montanaro A, Giordano R, De Padova F, Marangi AL, Ligorio VA, Santese D. IgA nephropathy in a patient with systemic lupus erythematosus. Nephrol Dial Transpl. 1998;13(7):1891\u20132.","journal-title":"Nephrol Dial Transpl"},{"key":"5092_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.31698\/ped.50012023010","volume":"50","author":"M Basabe","year":"2023","unstructured":"Basabe M, Troche A, Mart\u00ednez Pico M, Ayala Z. Nefropat\u00eda por IgA en una adolescente con lupus eritematoso sist\u00e9mico juvenil. Reporte de caso Pediatr\u00eda (Asunci\u00f3n). 2023;50:58\u201363.","journal-title":"Reporte de caso Pediatr\u00eda (Asunci\u00f3n)"},{"issue":"3","key":"5092_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.rbr.2014.10.011","volume":"56","author":"LS da Silva","year":"2016","unstructured":"da Silva LS, Almeida BL, de Melo AK, de Brito DC, Braz AS, Freire EA. IgA nephropathy in systemic lupus erythematosus patients: case report and literature review. Rev Bras Reumatol Engl Ed. 2016;56(3):270\u20133.","journal-title":"Rev Bras Reumatol Engl Ed"},{"issue":"3","key":"5092_CR26","first-page":"467","volume":"25","author":"A Corrado","year":"2007","unstructured":"Corrado A, Quarta L, Di Palma AM, Gesualdo L, Cantatore FP. IgA nephropathy in systemic lupus erythematosus. Clin Exp Rheumatol. 2007;25(3):467\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"5092_CR27","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.2169\/naika.91.3282","volume":"91","author":"E Fujikura","year":"2002","unstructured":"Fujikura E, Kimura T, Otaka A, Arima S, Satoh H, Itoh S, Hirabayashi Y, Sasaki T, Stoh T. [IgA nephropathy in the patient with systemic lupus erythematosus in remission]. Nihon Naika Gakkai Zasshi. 2002;91(11):3282\u20134.","journal-title":"Nihon Naika Gakkai Zasshi"},{"issue":"1","key":"5092_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s13730-020-00508-3","volume":"10","author":"M Lee","year":"2021","unstructured":"Lee M, Suzuki H, Kato R, Fukao Y, Nakayama M, Kano T, Makita Y, Suzuki Y. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy. CEN Case Rep. 2021;10(1):17\u201322.","journal-title":"CEN Case Rep"},{"issue":"8","key":"5092_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s12098-020-03636-x","volume":"88","author":"H Sait","year":"2021","unstructured":"Sait H, Gangadharan H, Gupta A, Aggarwal A, Jain M, Phadke SR. Monogenic Lupus with IgA Nephropathy Caused by Spondyloenchondrodysplasia with Immune Dysregulation. Indian J Pediatr. 2021;88(8):819\u201323.","journal-title":"Indian J Pediatr"},{"key":"5092_CR30","doi-asserted-by":"crossref","unstructured":"Patel AM, Karam LAR, Rojas SCF, Redfearn WE, Truong LD, Gonzalez JM. Rapidly progressive glomerulonephritis secondary to IgA nephropathy in a patient with systemic lupus erythematosus. Case Rep Nephrol. 2019:8354823.","DOI":"10.1155\/2019\/8354823"},{"issue":"SUPPL 1","key":"5092_CR31","first-page":"S20","volume":"27","author":"A Neuhaus","year":"2021","unstructured":"Neuhaus A, Montenegro A, Fortuna T, Kunz RZ, Alves GF, Trevisan B, Padilha GS, Coradin R, Willers T, Aubin FGT, et al. Systemic lupus erythematosus with iga nephropathy: Case report. J Clin Rheumatol. 2021;27(SUPPL 1):S20.","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"5092_CR32","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1053\/j.ajkd.2022.01.192","volume":"79","author":"Y Mahmoud","year":"2022","unstructured":"Mahmoud Y, Kuang A, Yap E. Unexpected IgA Nephropathy in a Patient With Systemic Lupus Erythematosus. Am J Kidney Dis. 2022;79(4):S57\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"5092_CR33","first-page":"e43091","volume":"15","author":"L Nunez Cuello","year":"2023","unstructured":"Nunez Cuello L, Perdomo W, Walgamage T, Walgamage M, Raut R. Unmasking Renal Disease in Systemic Lupus Erythematosus: Beyond Lupus Nephritis. Cureus. 2023;15(8):e43091.","journal-title":"Cureus"},{"issue":"10","key":"5092_CR34","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1097\/MS9.0000000000002401","volume":"86","author":"P Pokhrel","year":"2024","unstructured":"Pokhrel P, Neupane N, Karna NK, Pokhrel G, Chapagain N, Niraula A, Yadav AK. Unusual presentations in systemic lupus erythematosus with concurrent IgA nephropathy lesion: a rare case report from Eastern Nepal. Ann Med Surg (Lond). 2024;86(10):6140\u20134.","journal-title":"Ann Med Surg (Lond)"},{"issue":"12","key":"5092_CR35","first-page":"13945","volume":"11","author":"XC Xu","year":"2018","unstructured":"Xu XC, Zhang YM. Protein-losing enteropathy and iga nephropathy in a man with systemic lupus erythematosus: A case report. Int J Clin Exp Med. 2018;11(12):13945\u20138.","journal-title":"Int J Clin Exp Med"},{"key":"5092_CR36","doi-asserted-by":"crossref","unstructured":"Moola SMZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P-F. Chap. 7: systematic reviews of etiology and risk. In: Aromataris E. MZ, editor. Adelaide, Australia: JBI; 2020.","DOI":"10.46658\/JBIRM-17-06"},{"issue":"19","key":"5092_CR37","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"1","key":"5092_CR38","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12882-024-03804-7","volume":"25","author":"GB Gutierrez-Peredo","year":"2024","unstructured":"Gutierrez-Peredo GB, Montano-Castellon I, Gutierrez-Peredo AJ, Lopes MB, Tapioca FPM, Guimaraes MGM, Montano-Castellon S, Guedes SA, da Costa FPM, Mattoso RJC, et al. The urine protein\/creatinine ratio as a reliable indicator of 24-h urine protein excretion across different levels of renal function and proteinuria: the TUNARI prospective study. BMC Nephrol. 2024;25(1):418.","journal-title":"BMC Nephrol"},{"issue":"6","key":"5092_CR39","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s11255-021-03021-3","volume":"54","author":"P Zhai","year":"2022","unstructured":"Zhai P, Huang Y, Yue S, Yang X, Luo J, Zhang Y, Mei X, Bi L, Zhai W, Ren X, et al. Diagnostic efficacy and influence factors of urinary protein\/creatinine ratio replacing 24-h urine protein as an evaluator of proteinuria in children. Int Urol Nephrol. 2022;54(6):1409\u201316.","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"5092_CR40","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s11255-023-03512-5","volume":"55","author":"X Tang","year":"2023","unstructured":"Tang X, Zheng J, Jiang X, Wan F, Hou X, Liu S, Zhang M, Song Y, Ye T, Yu J. The significance of galactose-deficient immunoglobulin A1 staining in kidney diseases with IgA deposition. Int Urol Nephrol. 2023;55(8):2119\u201329.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"5092_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","volume":"9","author":"E Stamellou","year":"2023","unstructured":"Stamellou E, Seikrit C, Tang SCW, Boor P, Tesar V, Floege J, Barratt J, Kramann R. IgA nephropathy. Nat Rev Dis Primers. 2023;9(1):67.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"5092_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","volume":"18","author":"D Pitcher","year":"2023","unstructured":"Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, Steenkamp R, Wong K, Turner AN, Wang K, et al. Long-Term Outcomes in IgA Nephropathy. Clin J Am Soc Nephrol. 2023;18(6):727\u201338.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"5092_CR43","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1001\/jamainternmed.2019.0600","volume":"179","author":"SJ Barbour","year":"2019","unstructured":"Barbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Er L, Espino-Hernandez G, Kim SJ, et al. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. JAMA Intern Med. 2019;179(7):942\u201352.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"5092_CR44","doi-asserted-by":"publisher","first-page":"e2891","DOI":"10.1097\/MD.0000000000002891","volume":"95","author":"M Galindo-Izquierdo","year":"2016","unstructured":"Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, Lopez-Longo FJ, Calvo-Alen J, Olive A, Fernandez-Nebro A, Martinez-Taboada V, Vela-Casasempere P, Freire M, et al. Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER). Med (Baltim). 2016;95(9):e2891.","journal-title":"Med (Baltim)"},{"issue":"2","key":"5092_CR45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, O\u2019Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford). 2016;55(2):252\u201362.","journal-title":"Rheumatology (Oxford)"},{"key":"5092_CR46","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2147\/CIA.S455115","volume":"19","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhang Q, Duan Z, Chen P, Chen JJ, Li MX, Zhang JJ, Huo YH, Zhang WX, Yang C, et al. External Validation of the International IgA Nephropathy Prediction Tool in Older Adult Patients. Clin Interv Aging. 2024;19:911\u201322.","journal-title":"Clin Interv Aging"},{"issue":"12","key":"5092_CR47","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/nep.13667","volume":"25","author":"Q Wen","year":"2020","unstructured":"Wen Q, Rong R, Zhou Q, Tang X, Yang Q, Chen W, Yu X. Clinical, pathological characteristics and outcomes of immunoglobulin A nephropathy patients with different ages. Nephrol (Carlton). 2020;25(12):906\u201312.","journal-title":"Nephrol (Carlton)"},{"key":"5092_CR48","doi-asserted-by":"publisher","first-page":"e19917","DOI":"10.7717\/peerj.19917","volume":"13","author":"H Li","year":"2025","unstructured":"Li H, Qian C, Huang J, Sun M. Inflammatory and nutritional indexes as predictors of acute kidney injury in patients with Immunoglobulin A nephropathy: a retrospective study. PeerJ. 2025;13:e19917.","journal-title":"PeerJ"},{"issue":"11\u201312","key":"5092_CR49","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1159\/000533847","volume":"54","author":"S Li","year":"2023","unstructured":"Li S, Luo Q, Fan Y, Zhao C, Huang F, Xia X, Chen W. Clinicopathological Characteristics and Prognosis of Lupus Nephritis Patients with Acute Kidney Injury. Am J Nephrol. 2023;54(11\u201312):536\u201345.","journal-title":"Am J Nephrol"},{"issue":"7","key":"5092_CR50","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1007\/s10067-025-07520-x","volume":"44","author":"W Bai","year":"2025","unstructured":"Bai W, Gui Y, Liu J, Chen Y, Duan X, Li H, Wei W, Wu L, Liu S, Wang Y, et al. Management of newly diagnosed lupus nephritis in China: An implementation study based on the 2023 EULAR recommendations. Clin Rheumatol. 2025;44(7):2729\u201339.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"5092_CR51","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani S, Meara A, Rovin BH. Update on Lupus Nephritis. Clin J Am Soc Nephrol. 2017;12(5):825\u201335.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5092_CR52","doi-asserted-by":"publisher","first-page":"19732","DOI":"10.1038\/srep19732","volume":"6","author":"C Yuste","year":"2016","unstructured":"Yuste C, Rivera F, Moreno JA, Lopez-Gomez JM. Haematuria on the Spanish Registry of Glomerulonephritis. Sci Rep. 2016;6:19732.","journal-title":"Sci Rep"},{"issue":"2","key":"5092_CR53","doi-asserted-by":"publisher","first-page":"608","DOI":"10.4103\/jfmpc.jfmpc_960_21","volume":"11","author":"RS Rana","year":"2022","unstructured":"Rana RS, Naik B, Yadav M, Singh U, Singh A, Singh S. Serum complements and immunoglobulin profiles in systemic lupus erythematosus patients: An observational study at a teaching hospital. J Family Med Prim Care. 2022;11(2):608\u201313.","journal-title":"J Family Med Prim Care"},{"key":"5092_CR54","doi-asserted-by":"crossref","unstructured":"Hou X, Liang Y, Zhang W, Li R. The clinical and pathological effects of serum C3 level and mesangial C3 intensity in patients with IgA nephropathy. Anal Cell Pathol (Amst). 2024:8889306.","DOI":"10.1155\/2024\/8889306"},{"issue":"1","key":"5092_CR55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12882-019-1420-0","volume":"20","author":"TD Bi","year":"2019","unstructured":"Bi TD, Zheng JN, Zhang JX, Yang LS, Liu N, Yao L, Liu LL. Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study. BMC Nephrol. 2019;20(1):244.","journal-title":"BMC Nephrol"},{"issue":"4","key":"5092_CR56","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2215\/CJN.01860213","volume":"9","author":"XJ Zhou","year":"2014","unstructured":"Zhou XJ, Cheng FJ, Zhu L, Lv JC, Qi YY, Hou P, Zhang H. Association of systemic lupus erythematosus susceptibility genes with IgA nephropathy in a Chinese cohort. Clin J Am Soc Nephrol. 2014;9(4):788\u201397.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5092_CR57","doi-asserted-by":"crossref","unstructured":"Kim JS, Hwang HS, Lee SH, Kim YG, Moon JY, Kong JY, Jeong KH. Clinical relevance of serum galactose deficient IgA1 in patients with IgA nephropathy. J Clin Med. 2020;9(11).","DOI":"10.3390\/jcm9113549"},{"issue":"3","key":"5092_CR58","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.kint.2017.10.019","volume":"93","author":"H Suzuki","year":"2018","unstructured":"Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93(3):700\u20135.","journal-title":"Kidney Int"},{"issue":"12","key":"5092_CR59","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1093\/ndt\/gfz152","volume":"35","author":"CA Cassol","year":"2020","unstructured":"Cassol CA, Bott C, Nadasdy GM, Alberton V, Malvar A, Nagaraja HN, Nadasdy T, Rovin BH, Satoskar AA. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy. Nephrol Dial Transpl. 2020;35(12):2123\u20139.","journal-title":"Nephrol Dial Transpl"},{"issue":"23","key":"5092_CR60","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","volume":"373","author":"T Rauen","year":"2015","unstructured":"Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, et al. Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. N Engl J Med. 2015;373(23):2225\u201336.","journal-title":"N Engl J Med"},{"issue":"5","key":"5092_CR61","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2017.9362","volume":"318","author":"J Lv","year":"2017","unstructured":"Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, et al. Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. JAMA. 2017;318(5):432\u201342.","journal-title":"JAMA"},{"issue":"6","key":"5092_CR62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/RHU.0000000000000395","volume":"22","author":"MV Collado","year":"2016","unstructured":"Collado MV, Dorado E, Rausch S, Gomez G, Khoury M, Zazzetti F, Gargiulo M, Suarez L, Chaparro R, Paira S, et al. Long-term Outcome of Lupus Nephritis Class II in Argentine Patients: An Open Retrospective Analysis. J Clin Rheumatol. 2016;22(6):299\u2013306.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"5092_CR63","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10067-021-05909-y","volume":"41","author":"S Wang","year":"2022","unstructured":"Wang S, Chen D, Zuo K, Xu F, Hu W. Long-term renal outcomes of mesangial proliferative lupus nephritis in Chinese patients. Clin Rheumatol. 2022;41(2):429\u201336.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5092_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.ajkd.2019.01.026","volume":"74","author":"LJ Liu","year":"2019","unstructured":"Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN, Sui GL, Chen YQ, Lv JC, Zhang H. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial. Am J Kidney Dis. 2019;74(1):15\u201322.","journal-title":"Am J Kidney Dis"},{"key":"5092_CR65","doi-asserted-by":"crossref","unstructured":"Zhang J, Lu X, Feng J, Li H, Wang S. Effects of hydroxychloroquine on proteinuria in IgA nephropathy: a systematic review and meta-analysis. Biomed Res Int. 2021:9171715.","DOI":"10.1155\/2021\/9171715"},{"issue":"7","key":"5092_CR66","doi-asserted-by":"publisher","first-page":"sfaf171","DOI":"10.1093\/ckj\/sfaf171","volume":"18","author":"X Jia","year":"2025","unstructured":"Jia X, Xiang W, Peng H, Yu J, Wang X, Ye H, Wu H, Tang R, Xia X, Chen W. Induction therapy for class I\/II lupus nephritis with glucocorticoid monotherapy associates with higher relapse and poorer kidney outcomes. Clin Kidney J. 2025;18(7):sfaf171.","journal-title":"Clin Kidney J"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05092-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:02:54Z","timestamp":1785758574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05092-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5092"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05092-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human participants were involved in this study. The study protocol was reviewed and approved by the research ethics committee of Chinese PLA General Hospital (approval no. 2025KY113-KS001) in accordance with the Declaration of Helsinki. Written informed consent to participate was obtained from the patient.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for the publication of de-identified clinical data, including demographic characteristics (age, sex) and pathological findings.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"451"}}